ACH
Accendra Health, Inc.
NYSE · Healthcare · Medical - Distribution · US
$1.21
−0.82%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-55.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 20, 2026 | Galloway Heath H · officer: EVP,General Counsel & CorpSecy | F-InKind | 1,822 | $2.91 |
| May 19, 2026 | Leon Jonathan A · officer: EVP & CFO | F-InKind | 1,770 | $3.04 |
| May 19, 2026 | Bernocchi Perry A · officer: EVP, Chief Operating Officer | F-InKind | 7,908 | $3.04 |
| May 19, 2026 | Galloway Heath H · officer: EVP,General Counsel & CorpSecy | F-InKind | 966 | $3.04 |
| May 19, 2026 | Pesicka Edward A · director, officer: President & CEO | F-InKind | 17,692 | $3.04 |
| May 18, 2026 | Klemash Stephen W · director | A-Award | 31,191 | $0.00 |
| May 18, 2026 | Kline Teresa L. · director | A-Award | 31,191 | $0.00 |
| May 18, 2026 | Gardner-Smith Kenneth · director | A-Award | 31,191 | $0.00 |
| May 18, 2026 | Bingham Gwendolyn M · director | A-Award | 31,191 | $0.00 |
| May 18, 2026 | Beck Mark A · director | A-Award | 31,191 | $0.00 |
| Mar 24, 2026 | Galloway Heath H · officer: EVP,General Counsel & CorpSecy | F-InKind | 9,347 | $2.03 |
| Mar 24, 2026 | Bernocchi Perry A · officer: EVP, Chief Operating Officer | F-InKind | 20,841 | $2.03 |
| Mar 24, 2026 | Leon Jonathan A · officer: EVP & CFO | F-InKind | 11,286 | $2.03 |
| Mar 24, 2026 | Pesicka Edward A · director, officer: President & CEO | F-InKind | 58,945 | $2.03 |
| Mar 10, 2026 | Leon Jonathan A · officer: EVP & CFO | A-Award | 85,067 | $0.00 |
| Mar 10, 2026 | Bernocchi Perry A · officer: EVP, Chief Operating Officer | A-Award | 108,696 | $0.00 |
| Mar 10, 2026 | Galloway Heath H · officer: EVP,General Counsel & CorpSecy | A-Award | 61,437 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 20, 2026